| __timestamp | Dr. Reddy's Laboratories Limited | Novartis AG |
|---|---|---|
| Wednesday, January 1, 2014 | 38783000000 | 14993000000 |
| Thursday, January 1, 2015 | 42585000000 | 14247000000 |
| Friday, January 1, 2016 | 45702000000 | 14192000000 |
| Sunday, January 1, 2017 | 46372000000 | 14997000000 |
| Monday, January 1, 2018 | 46910000000 | 16471000000 |
| Tuesday, January 1, 2019 | 48890000000 | 14369000000 |
| Wednesday, January 1, 2020 | 50129000000 | 14197000000 |
| Friday, January 1, 2021 | 54559000000 | 14886000000 |
| Saturday, January 1, 2022 | 62081000000 | 14253000000 |
| Sunday, January 1, 2023 | 105931000000 | 12489000000 |
| Monday, January 1, 2024 | 77201000000 | 12566000000 |
Unlocking the unknown
In the competitive world of pharmaceuticals, managing Selling, General, and Administrative (SG&A) expenses is crucial for profitability. Over the past decade, Novartis AG and Dr. Reddy's Laboratories Limited have showcased contrasting strategies in this domain. From 2014 to 2023, Dr. Reddy's Laboratories saw a staggering 173% increase in SG&A expenses, peaking in 2023. In contrast, Novartis AG maintained a relatively stable SG&A cost, with a slight decrease of around 17% over the same period. This suggests Novartis's focus on cost efficiency, while Dr. Reddy's might be investing heavily in growth and expansion. The data for 2024 is incomplete, highlighting the dynamic nature of financial strategies. As these companies navigate the ever-evolving pharmaceutical landscape, their approach to SG&A costs will be pivotal in determining their market position.
Novartis AG and Sanofi: SG&A Spending Patterns Compared
Breaking Down SG&A Expenses: Novartis AG vs Bristol-Myers Squibb Company
Comparing SG&A Expenses: Novartis AG vs Gilead Sciences, Inc. Trends and Insights
Comparing SG&A Expenses: Novartis AG vs Cytokinetics, Incorporated Trends and Insights
SG&A Efficiency Analysis: Comparing Novartis AG and Amneal Pharmaceuticals, Inc.
Takeda Pharmaceutical Company Limited or Dr. Reddy's Laboratories Limited: Who Manages SG&A Costs Better?
Operational Costs Compared: SG&A Analysis of Insmed Incorporated and Dr. Reddy's Laboratories Limited
Selling, General, and Administrative Costs: Dr. Reddy's Laboratories Limited vs Sarepta Therapeutics, Inc.
Who Optimizes SG&A Costs Better? Dr. Reddy's Laboratories Limited or Ascendis Pharma A/S
Dr. Reddy's Laboratories Limited or Rhythm Pharmaceuticals, Inc.: Who Manages SG&A Costs Better?
Dr. Reddy's Laboratories Limited and Vericel Corporation: SG&A Spending Patterns Compared
Dr. Reddy's Laboratories Limited and MannKind Corporation: SG&A Spending Patterns Compared